ArticleBMC cancer2019

ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial.

Qingguo Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.